Med BioGene Reports No Revenues, $164K Loss for Q1
June 29, 2011
Med BioGene Reports No Revenues, $164K Loss for Q1
During the past few months, the genomic test development firm has signed a deal to develop and commercialize its NSCLC test and completed a private placement.
Full-text access for registered users only.
Existing users login here.
New to GenomeWeb? Register here quickly for free access.
New to GenomeWeb? Register here quickly for free access.